Charney Laurence N
Visual SEC Form 4 history across 1 companies, 3 transactions and 2 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
sale at TG THERAPEUTICS, INC. on Sep 10, 2026 valued at $274,800.
Review SEC filingNo open-market insider purchase is available.
Associated companies
Visual map of known reporting history
Latest insider transactions
Form 4 filings from available history. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #218033 | TGTX | Charney Laurence N | DIR | sale | 5.00k | -$27.4M | S | 09/14 | 09/10 |
| #215226 | TGTX | Charney Laurence N | DIR | gift | 13.1k | $0 | G | 01/29 | 01/29 |
| #215225 | TGTX | Charney Laurence N | DIR | gift | 30.0k | $0 | G | 01/29 | 01/28 |
Charney Laurence N Insider Activity FAQ
SEC Form 4 context
Who is Charney Laurence N?
Charney Laurence N is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001407451.
Which companies has Charney Laurence N reported transactions for?
TG THERAPEUTICS, INC.
When was Charney Laurence N's latest insider buy?
No open-market insider purchase is available for this period.
When was Charney Laurence N's latest insider sale?
sale at TG THERAPEUTICS, INC. on Sep 10, 2026 valued at $274,800.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.